Real-world assessment of AR-LBD mutations in metastatic castration-resistant prostate cancer.

被引：0
|
作者：
Antonarakis, Emmanuel S.
Zhang, Nicole
Saha, Jayati
Nevalaita, Liina
Shell, Scott A.
Garratt, Chris
Ikonen, Tarja
Fizazi, Karim
机构：
[1] Univ Minnesota, Phys Oncol Clin, Minneapolis, MN USA
[2] Guardant Hlth Inc, Palo Alto, CA USA
[3] Guardant Hlth, Redwood City, CA USA
[4] Orion Corp, Orion Pharma, Espoo, Finland
[5] Orion Pharma, Nottingham, England
[6] Orion Pharma, Espoo, Finland
[7] Univ Paris Saclay, Inst Gustave Roussy, Villejuif, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
204
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Beyond Frontline Therapy with Abiraterone and Enzalutamide in Metastatic Castration-Resistant Prostate Cancer: A Real-World US Study
    Shore, Neal D.
    Ionescu-Ittu, Raluca
    Laliberte, Francois
    Yang, Lingfeng
    Lejeune, Dominique
    Yu, Louise
    Duh, Mei Sheng
    Mahendran, Malena
    Kim, Jeri
    Ghate, Sameer R.
    CLINICAL GENITOURINARY CANCER, 2021, 19 (06) : 480 - 490
  • [32] REAL-WORLD TREATMENT PATTERNS AND TREATMENT SEQUENCES IN THE METASTATIC CASTRATION-RESISTANT PROSTATE CANCER SETTINGS ACROSS EUROPE
    Castro, E.
    Orji, C.
    Ribbands, A.
    Butcher, J.
    Walley, M.
    Li, W.
    Ghate, S.
    VALUE IN HEALTH, 2024, 27 (06) : S227 - S227
  • [33] Exposure–response analyses of abiraterone and its metabolites in real-world patients with metastatic castration-resistant prostate cancer
    M. van Nuland
    S. L. Groenland
    A. M. Bergman
    N. Steeghs
    H. Rosing
    N. Venekamp
    A. D. R. Huitema
    J. H. Beijnen
    Prostate Cancer and Prostatic Diseases, 2020, 23 : 244 - 251
  • [34] PD-1 inhibitor plus anlotinib for metastatic castration-resistant prostate cancer: a real-world study
    Du, Xin-Xing
    Dong, Yan-Hao
    Zhu, Han-Jing
    Fei, Xiao-Chen
    Gong, Yi-Ming
    Xia, Bin-Bin
    Wu, Fan
    Wang, Jia-Yi
    Liu, Jia-Zhou
    Fan, Lian-Cheng
    Wang, Yan-Qing
    Dong, Liang
    Zhu, Yin-Jie
    Pan, Jia-Hua
    Dong, Bai-Jun
    Xue, Wei
    ASIAN JOURNAL OF ANDROLOGY, 2023, 25 (02) : 179 - +
  • [35] REAL-WORLD OUTCOMES AND TREATMENTS PATTERNS OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER PATIENTS: AN ITALIAN RETROSPECTIVE STUDY
    Danesi, V
    Roncadori, A.
    Massa, I
    Balzi, W.
    Maltoni, R.
    Farolfi, A.
    VALUE IN HEALTH, 2022, 25 (12) : S49 - S49
  • [36] Metastatic castration-resistant prostate cancer
    Henriques, Vanessa
    Wenzel, Mike
    Demes, Melanie-Christin
    Koellermann, Jens
    PATHOLOGE, 2021, 42 (04): : 431 - 438
  • [37] Real-world treatment (Tx) patterns of metastatic castration-resistant prostate cancer (mCRPC) patients (pts) in the US
    Shore, N.
    Laliberte, F.
    Ionescu-Ittu, R.
    Gayle, A.
    Amin, S.
    Yang, L.
    Payne, S.
    Mahendran, M.
    Lejeune, D.
    Yu, L.
    Burgents, J.
    Duh, M. S.
    Ghate, S.
    ANNALS OF ONCOLOGY, 2020, 31 : S534 - S535
  • [38] A Compendium of AR Splice Variants in Metastatic Castration-Resistant Prostate Cancer
    Isebia, Khrystany T.
    Lolkema, Martijn P.
    Jenster, Guido
    de Wit, Ronald
    Martens, John W. M.
    van Riet, Job
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (06)
  • [39] Real-world treatment patterns in French metastatic castration-resistant prostate cancer patients under abiraterone or enzalutamide
    Scailteux, L. M.
    Vincendeau, S.
    Gravis, G.
    Mathieu, R.
    Balusson, F.
    Kerbrat, S.
    Oger, E.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2023, 37 : 10 - 11
  • [40] Real-world cabazitaxel safety: the Italian early-access program in metastatic castration-resistant prostate cancer
    Bracarda, Sergio
    Gernone, Angela
    Gasparro, Donatello
    Marchetti, Paolo
    Ronzoni, Monica
    Bortolus, Roberto
    Fratino, Lucia
    Basso, Umberto
    Mazzanti, Roberto
    Messina, Caterina
    Tucci, Marcello
    Boccardo, Francesco
    Carteni, Giacomo
    Pinto, Carmine
    Fornarini, Giuseppe
    Mattioli, Rodolfo
    Procopio, Giuseppe
    Chiuri, Vincenzo
    Scotto, Tiziana
    Dondi, Davide
    Di Lorenzo, Giuseppe
    FUTURE ONCOLOGY, 2014, 10 (06) : 975 - 983
12345